Who owns VINCERA PHARMA INC?
- Ticker: VINC
- CUSIP Number: 92731l106
Tip: Access positions for across all investors
Analyze quarterly positions in Vincera Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vincera Pharma stock
Who bought or sold VINCERA PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Goldman Sachs Group | 1.7M | $2.0M | -17% | Dec 2023 |
|
| Sage Rhino Capital | 1.7M | $2.0M | 0% | Dec 2023 |
|
| Long Focus Capital Management | 1.1M | $1.3M | 0% | Dec 2023 |
|
| Bank of America Corporation | 1.1M | $1.3M | -25% | Dec 2023 |
|
| Vanguard Group | 513k | $606k | 0% | Dec 2023 |
|
| Kingdon Capital Management | 385k | $454k | 0% | Dec 2023 |
|
| Point72 Asset Management | 345k | $407k | 0% | Dec 2023 |
|
| Tejara Capital | 233k | $275k | 0% | Dec 2023 |
|
| Citadel Advisors | 197k | $233k | 17% | Dec 2023 |
|
| Walleye Trading Advisors | 115k | $136k | 0% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 114k | $135k | 0% | Dec 2023 |
|
| T. Rowe Price Associates | 40k | $48k | 0% | Dec 2023 |
|
| Millennium Management | 35k | $41k | -7% | Dec 2023 |
|
| GW & Wade | 11k | $13k | 0% | Dec 2023 |
|
| LMR Partners | 10k | $12k | 0% | Dec 2023 |
|
| UBS Group | 2.9k | $3.5k | -49% | Dec 2023 |
|
| Wells Fargo & Company | 133.00 | $157.006500 | 6% | Dec 2023 |
|
| Barclays | 23.00 | $0 | -99% | Dec 2023 |
|
Who sold out of Vincera Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Clearline Capital | Sep 2023 | 99k | $100k |